Melanopsin modulates refractive development and myopia. (January 2022)

• Record Type: Journal Article
• Authors: Chakraborty, Ranjay; Landis, Erica G.; Mazade, Reece; Yang, Victoria; Strickland, Ryan; Hattar, Samer; Stone, Richard A.; Iuvone, P. Michael; Pardue, Machelle T.
• Is Part Of: Experimental eye research. Volume 214(2022)
• Publication Date: 2022-01
• Subjects: mRGCs Melanopsin-expressing retinal ganglion cells -- FD Form deprivation; Opn4 -- Melanopsin retinal ganglion cells (mRGCs) -- Dopamine -- 3, 4-Dihydroxyphenylacetic acid (DOPAC) -- L-3, 4-dihydroxyphenylalanine (L-DOPA); Ophthalmology -- Periodicals; Eye -- Periodicals; Œil -- Périodiques; Ophthalmology; Periodicals; Electronic journals; 612.8405
• DOI: 10.1016/j.exer.2021.108866
• Languages: English
• ISSNs: 0014-4835

Abstract

Abstract: Myopia, or nearsightedness, is the most common form of refractive abnormality and is characterized by excessive ocular elongation in relation to ocular power. Retinal neurotransmitter signaling, including dopamine, is implicated in myopic ocular growth, but the visual pathways that initiate and sustain myopia remain unclear. Melanopsin-expressing retinal ganglion cells (mRGCs), which detect light, are important for visual function, and have connections with retinal dopamine cells. Here, we investigated how mRGCs influence normal and myopic refractive development using two mutant mouse models: Opn4 −/− mice that lack functional melanopsin photopigments and intrinsic mRGC responses but still receive other photoreceptor-mediated input to these cells; and Opn4 DTA/DTA mice that lack intrinsic and photoreceptor-mediated mRGC responses due to mRGC cell death. In mice with intact vision or form-deprivation, we measured refractive error, ocular properties including axial length and corneal curvature, and the levels of retinal dopamine and its primary metabolite, L-3, 4-dihydroxyphenylalanine (DOPAC). Myopia was measured as a myopic shift, or the difference in refractive error between the form-deprived and contralateral eyes. We found that Opn4 −/− mice had altered normal refractive development compared to Opn4 +/+ wildtype mice, starting ∼4D more myopic but developing ∼2D greater hyperopia by 16 weeks of age. Consistent with hyperopia at older ages, 16 week-old Opn4 −/− mice also had shorter eyes compared to Opn4 +/+ mice (3.34 vs 3.42 mm). Opn4 DTA/DTA mice, however, were more hyperopic than both Opn4 +/+ and Opn4 −/− mice across development ending with even shorter axial lengths. Despite these differences, both Opn4 −/− and Opn4 DTA/DTA mice had ∼2D greater myopic shifts in response to form-deprivation compared to Opn4 +/+ mice. Furthermore, when vision was intact, dopamine and DOPAC levels were similar between Opn4 −/− and Opn4 +/+ mice, but higher in Opn4 DTA/DTA mice, which differed with age. However, form-deprivation reduced retinal dopamine and DOAPC by ∼20% in Opn4 −/− compared to Opn4 +/+ mice but did not affect retinal dopamine and DOPAC in Opn4 DTA/DTA mice. Lastly, systemically treating Opn4 −/− mice with the dopamine precursor L-DOPA reduced their form-deprivation myopia by half compared to non-treated mice. Collectively our findings show that disruption of retinal melanopsin signaling alters the rate and magnitude of normal refractive development, yields greater susceptibility to form-deprivation myopia, and changes dopamine signaling. Our results suggest that mRGCs participate in the eye's response to myopigenic stimuli, acting partly through dopaminergic mechanisms, and provide a potential therapeutic target underling myopia progression. We conclude that proper mRGC function is necessary for correct refractive development and protection from myopia progression. Highlights: Dysfunction in retinal melanopsin signaling alters refractive development in mice. Form-deprivation (FD) myopia is enhanced with disrupted melanopsin signaling. Retinal dopamine signaling is reduced in form-deprived mice lacking melanopsin. Systemic L-DOPA treatment attenuates FD myopia in melanopsin knockout mice. Melanopsin is vital for refractive development and slowing myopia progression.